Abstract: A cosmetic or dermatological composition which comprises carnitine, a precursor thereof, a metabolite thereof and/or a derivative thereof.

Abstract: Use of ascorbic acid for producing topical preparations with angiogenic effects.

Abstract: The invention relates to the use of preparations to be applied topically having a content of

Abstract: Use of preparations to be applied topically having a content of

Abstract: Use of

Abstract: Use of electrolytes for producing cosmetic or dermatological preparations for the treatment and prevention of dry skin, and the use of electrolytes for producing cosmetic and dermatological preparations for the treatment and prevention of dry skin and for enhancing the barrier function of the skin.

Abstract: The present invention uses calcium-releasing or binding substances for the targeted weakening or strengthening of the barrier function of the skin. The invention includes methods and compositions of using these substances.

Abstract: The invention relates to the use of one or more compounds from the bioquinone group for producing cosmetic or dermatological preparations for treating the scalp and the hair, in order to prolong the anagen phase and/or to treat and prevent seborrhoeic outbreaks, optionally with the additional use of one or more compounds from the group formed by carnitine, arginine, succinic acid, folic acid, conjugated fatty acids and their respective derivatives, in addition to antioxidants.

Abstract: The invention relates to the use of a compound or several compounds from the group of bioquinones a) in combination with a compound or several compounds from the group of potassium channel openers and/or b) in combination with a compound or several compounds from the group of 5-alpha-reductase inhibitors, for the production of cosmetic or dermatological preparations for treatment of the scalp and for hair in order to prolong the anagenic phase and/or for the treatment and prophylaxis of seborrhoeic symptoms, optionally by additionally using one or several compounds from the group formed from carnitine, arginine, succinic acid, folic acid, conjugated fatty acids and respectively the derivatives thereof, in addition to antioxidants.

Abstract: Topical formulations containing one or more compounds chosen from the group (A) consisting of sterols and biochemical precursors thereof in combination with a content of one or more compounds chosen from the group (B) consisting of ubiquinones and derivatives thereof and plastoquinones and derivatives thereof.

Abstract: Topical formulations containing one or more compounds chosen from the group (A) consisting of sterols and biochemical precursors thereof in combination with a content of one or more compounds chosen from the group (B) consisting of ubiquinones and derivatives thereof and plastoquinones and derivatives thereof.

Abstract: Use of topical formulations having a content of one or more compounds from the group consisting of ubiquinones and derivatives thereof for treatment of senile xerosis and/or exogenous ageing of the skin.

Abstract: Deodorizing or antibacterial compositions, in particular for use in cosmetic or topical formulations, characterized in that they comprisea) at least one 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol,b) at least one phenyl hydroxyalkyl ether having one, two or three carbon atoms in the alkyl radical,c) at least one glycerol monoester of a short-chain or medium-chain fatty acid andd) optionally glycerol monolaurate.

Abstract: Topical formulations having a content of one compound or several compounds from the group consisting of ubiquinones and derivatives thereof in combination with a content of one compound or several compounds from the group consisting of plastoquinones and derivatives thereof or formulations having a content of one compound or several compounds from the group consisting of plastoquinones and derivatives thereof.

Abstract: The invention provides a cosmetic or dermatological method for detecting and/or selectively quantifying individual microorganisms, and/or whole groups of microorganisms, which are present on human or animal skin, comprising the steps ofremoving a sample of the microflora of the human or animal skin,treating the sample with a deinhibiting medium, adding the treated sample to a culture medium which exhibits favorable growth conditions for a defined group of microorganisms but unfavorable growth conditions for other microorganisms, to produce a selective culture, and incubating the selective culture over a sufficiently long period of time, to allow only the group of microorganisms for which the culture medium exhibits favorable growth conditions the opportunity to multiply, in association with metabolic products, in particular CO.sub.

Abstract: Active compound combinations comprising a combination of at least one substance chosen from the group consisting of 2,4-O-furfurylidenesorbitol and alkyl ethers thereof and at least one substance chosen from the group consisting of tocopherols and tocopheryl esters, and cosmetic and dermatological light protection formulations comprising such active compound combinations.

Abstract: Use of carnosine or derivatives or analogs thereof or of the combination of the active compounds a) carnosine or derivatives or analogs thereof and b) urocanic acid or derivatives or analogs thereof, or in each case mixtures of these compounds, if appropriate in each case in combination with an antioxidant or a plurality of antioxidants and if appropriate with a suitable carrier, for cosmetic and dermatological purposes, in particular for the prophylaxis and treatment of photosensitive skin, in particular photodermatoses, and preferably polymorphic photodermatosis.

Abstract: Cosmetic and/or dermatological active compound combinations comprisinga) an active amount of biotin and/or biotin esters,b) an active amount of one or more .alpha.-hydroxycarboxylic acids of the formulaR'(R")(OH)C COOHand/or an active amount of one or more .alpha.-ketocarboxylic acids of the formulaR'C(O) COOHor their physiologically acceptable salts or esters wherein R' and R" represent H-; branched or unbranched C.sub.1-25 -alkyl- or C.sub.1-25 -alkyl-substituted by one or more carboxyl groups and/or hydroxyl groups and/or a aldehyde groups and/or oxo groups (keto groups); phenyl- or phenyl substituted by one or more carboxyl groups and/or hydroxyl groups and/or branched and/or unbranched C.sub.1-25 -alkyl groups; or wherein the .alpha.-carbon atom of the .alpha.

Abstract: The use of an active amount of cis-urocaninic acid as a light protection agent and/or antioxidant, if appropriate in a suitable galenic carrier, for cosmetic and/or dermatological purposes, the use of an active content of cis-urocaninic acid as a light protection agent and/or antioxidant in cosmetic and dermatological formulations, and the use of a mixture of cis- and trans-urocaninic acid as a light protection agent or antioxidant in cosmetic and dermatological formulations, wherein it must be ensured that at least the cis-urocaninic acid is present in an active concentration.

Abstract: A cosmetic or dermatological preparation comprising .delta.-aminolevulinic acid as an active ingredient.